Loading...

CMMB - Chemomab Therapeutics Ltd.

Top Biomed Signal for 11-27-2023
Top Biomed Stock Signal: CMMB


Loading Chart CMMB

Stock Signal Information


Signal

Top Biomed Stock Signal: CMMB
Report Date: 11-27-2023
Symbol: CMMB - Chemomab Therapeutics Ltd.
Sector:
Industry:
Top Biomed Stock Signal: CMMB

  CMMB Technical Analysis

Company Contact

Chemomab Therapeutics Ltd. (CMMB)
Building 7
Tel Aviv, 6158002
Phone: 972 77 331 0156
Website: https://www.chemomab.com
CEO: Dr. Adi Mor George Ph.D.

CMMB, Chemomab Therapeutics Ltd.

CMMB Chemomab Therapeutics Ltd. Logo Image

NASDAQ, NASDAQ Capital Market


Company Profile

Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was incorporated in 2011 and is based in Tel Aviv, Israel.